Seraseq next-generation sequencing (NGS) reference materials enable the promise of clinical genomics by helping scientists and clinicians build, validate, implement, and standardize better clinical genomics assays. Using highly innovative and patented technology, SeraCare designs and manufactures highly multiplexed, patient-like reference materials for NGS assays used by clinical and translational research laboratories that conduct molecular testing of patient samples for:
Somatic cancer: Heme Malignancy (Myeloid), Liquid Biopsy, Tumor Mutational Burden (TMB & Blood TMB), MRD monitoring, NTRK / fusion, Breast, Lung, Brain and Micosattelite Instability (MSI).
Inherited disease
Reproductive health: Prenatal Testing, NIPT, PGT-A
Infectious disease: HIV
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling